Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Metastatic Gastric Adenocarcinoma × Ramucirumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Adenocarcinoma 3 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Neoplasm Metastasis 1 Metastatic Gastric Adenocarcinoma 1 Liver Neoplasms 1 HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma 1 Gastroesophageal Junction Adenocarcinoma 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Breast Neoplasms 1

Interventions

Ramucirumab 1 Fluorouracil 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02314117 2021-08-26

RAINFALL

Eli Lilly and Company

Phase 3 Completed

645 enrolled 22 charts

Gastrointestinal

Metastatic Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡